News
Starting new diabetes drugs less likely for racial minorities, Medicare Advantage beneficiaries
More work is needed to understand why DPP-4 inhibitors, GLP-1 receptor agonists, and SGLT2 inhibitors are not being used as often in patients that...
News
Pembrolizumab prolonged PFS vs. brentuximab vedotin in r/r Hodgkin lymphoma
Pembrolizumab should be considered “the preferred treatment option and the standard of care” for patients with classic Hodgkin lymphoma not...
News
Pyrotinib bests lapatinib in HER2+ metastatic breast cancer
Patients who received pyrotinib had longer progression-free survival but a higher rate of grade 3 diarrhea.
News
Trastuzumab deruxtecan proves active in HER2-mutated NSCLC
The confirmed overall response rate was 61.9%, and the median duration of response has not been reached.
News
Short-course radiotherapy and chemo may reduce treatment failures in high-risk rectal cancer
“Could it be we’re merely delaying distant metastases versus preventing them by more consistent use of systemic therapy sooner?”
News
DOACs linked to lower fracture risk versus warfarin in AFib patients
The results suggest women may particularly benefit from DOAC use.
News
Suicide prevention one key focus of upcoming NIMH strategic plan
The much broader strategic plan to guide research efforts and priorities is set to be released in the next few weeks, Dr. Joshua Gordon said.
News
NSDUH data might underestimate substance use by pregnant women
Substance use disorders may be more prevalent than previously appreciated.